“Hypertriglyceridemia: From Biochemical Aberration to Cardiometabolic Syndrome - Emerging Pathophysiology, Clinical Challenges, and Novel Therapeutics ”. 2025. Diabzen 3 (2): 11-15. https://www.thediabzen.com/index.php/d/article/view/12.